N-(2-chloropyridin-3-yl)-2-{[6-methyl-4-oxo-3-(propan-2-yl)-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-2-yl]sulfanyl}acetamide

Compound number
MolPort-019-714-245
IUPAC
N-(2-chloropyridin-3-yl)-2-{[6-methyl-4-oxo-3-(propan-2-yl)-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-2-yl]sulfanyl}acetamide
IUPAC traditional
N-(2-chloropyridin-3-yl)-2-({3-isopropyl-6-methyl-4-oxo-5H-pyrrolo[3,2-d]pyrimidin-2-yl}sulfanyl)acetamide
SMILES
CC(C)n1c(SCC(=O)Nc2cccnc2Cl)nc2cc(C)[nH]c2c1=O
InChI key
DOCLJQOQTJNQDL-UHFFFAOYSA-N
Molecular formula
Molecular weight
391.87
DMSO Solubility
Not known

Marketplace Offers

Vitas M Chemical Limited

Direct S&H to USA:
220.00 USD
Catalog
Screening compound
Ships out
15 business days
Purity
>90%
Last updated
this week
In warehouse
99.00 mg

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 mg October 25, 2022 30.22 USD
Add to Cart Buy
2 mg October 25, 2022 31.93 USD
Add to Cart Buy
3 micromol October 25, 2022 30.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-019-714-245

Names, Synonyms and 3rd Party Identifiers

Name
N-(2-Chloro-pyridin-3-yl)-2-(3-isopropyl-6-methyl-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-ylsulfanyl)-acetamide
N-(2-chloropyridin-3-yl)-2-{[6-methyl-4-oxo-3-(propan-2-yl)-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-2-yl]sulfanyl}acetamide

InChI

InChI
1/C17H18ClN5O2S/c1-9(2)23-16(25)14-12(7-10(3)20-14)22-17(23)26-8-13(24)21-11-5-4-6-19-15(11)18/h4-7,9,20H,8H2,1-3H3,(H,21,24)
InChI key
DOCLJQOQTJNQDL-UHFFFAOYSA-N

Formula

Molecular formula
C17H18ClN5O2S
Molecular weight
391.87

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback